-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JWaoPUS5CRpEOK0bRMRYIXh71NB54zkF5GcV0ut4yct3NTeoRkjPK9VLJ7pIkNUq HElGLsWqj37fL8d2PQu2vw== 0001127602-10-009269.txt : 20100322 0001127602-10-009269.hdr.sgml : 20100322 20100322170112 ACCESSION NUMBER: 0001127602-10-009269 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100322 FILED AS OF DATE: 20100322 DATE AS OF CHANGE: 20100322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DWEK RAYMOND CENTRAL INDEX KEY: 0001231617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 10697082 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-03-22 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231617 DWEK RAYMOND 1 Common Stock 2010-03-22 4 M 0 800 24.39 A 800 D Common Stock 2010-03-22 4 S 0 800 57.0575 D 0 D Stock Options 24.39 2010-03-22 4 M 0 800 0 D 2006-06-29 2015-06-29 Common Stock 800 19200 D The exercise of stock options and corresponding sale of common stock were carried out pursuant to a Rule 10b5-1 Plan, which the reporting person entered into on February 26, 2010. /s/ Paul A. Mahon under Power of Attorney 2010-03-22 -----END PRIVACY-ENHANCED MESSAGE-----